Original content available for non-commercial use under a Creative Commons license, except where noted.
This is my second time using this particular Lab. I've previous positive experience with Sis (when formerly known as Infiniti Labs) Anavar, so my expectations were some what inflated:)
Firstly, I was really impressed by the immaculate packaging of this product, which shows how much effort went into its manufacturing and marketing. I ran this product at a weekly dose of 400mg, in conjunction with Mast e and Test. Prior to introducing Sis Tren e into my current cycle, I was already using a different Labs Tren at a slightly higher dose of 500mg weekly. To be honest, I did not notice any difference, even when running Sis Tren e at a slightly lowered dose of 400mg for 5 weeks in total. I continued with making strength gains with a noticeable reduction in body fat, even though my diet wasn't always on point. I have had no adverse effects from the Tren, unless if you want to include night sweats. Overall, I am very satisfied with the results I got from use of this product.
So were the cruise executives concerned that their fabulous wealth would be touched? Hardly. This is an industry of fat-cat executives who know that they are untouchable. It is fundamentally different from other industries where racketeers are prosecuted or where the top dogs will eventually do the right thing for the shareholders when the corporation is caught doing something wrong. Consider what Wells Fargo & Co. Chief Executive John Stumpf recently did when his company was caught opening millions of checking, saving and credit card accounts for customers without their knowledge. Stumpf agreed to forfeit compensation worth about $45 million from around 910,000 shares in un-vested stock awards, and agreed to forego his bonus this year. Another executive who was in charge of the division where much of the illegal activity took place, will give up about $19 million worth of stock. Wells Fargo’s board of directors also said that other executives could lose stock awards or even other compensation already paid to them.